Sales of Novo Nordisk’s (NVO) blockbuster weight-loss drug Wegovy doubled in the fourth quarter, but the Danish pharmaceutical giant warns that sales growth for all its drugs — including Ozempic — is expected to slow in the coming year.
Read more...
Hence then, the article about the ozempic boom is slowing down was published today ( ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( The Ozempic boom is slowing down )
Last updated :
Also on site :
- M31 and Ambiq Collaborate on TSMC N12e® Foundation IP to Address Demanding SoC Power and Area Targets
- India's power shortages exceed summer peak as weak monsoon hits hydropower
- Configit wurde im Gartner® Hype Cycle™ für Discrete Manufacturing Technologies 2026 als Beispielanbieter aufgeführt